Richard Moulson, an accountant and biotech executive, has been named chief financial officer of Evgen Pharma Plc, a clinical stage drug development company in the UK. The appointment takes effect on 1 March. Mr Moulson qualified as an accountant at Coopers & Lybrand and subsequently worked in corporate finance at Deutsche Morgan Grenfell before joining the life science industry as a CFO. His most recent position was as CFO of Cogent Breeding Ltd. Mr Moulson graduated in zoology from the University of Exeter.
Evgen Pharma announced the appointment on 17 January 2017.
Copyright 2017 Evernow Publishing Ltd